We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
Cap. Flow
+$81.1M
Cap. Flow %
34.53%
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.52M
2
KDP icon
Keurig Dr Pepper
KDP
+$2.4M
3
WFC icon
Wells Fargo
WFC
+$2.19M
4
AET
Aetna Inc
AET
+$2.17M
5
PNC icon
PNC Financial Services
PNC
+$2.15M

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$1.39M
2
ETN icon
Eaton
ETN
+$1.38M
3
CB
CHUBB CORPORATION
CB
+$1.35M
4
XEC
CIMAREX ENERGY CO
XEC
+$1.32M
5
DVA icon
DaVita
DVA
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 15.9%
2 Consumer Discretionary 14.51%
3 Industrials 13.73%
4 Financials 13.03%
5 Healthcare 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMC icon
126
Vulcan Materials
VMC
$37.4B
$612K 0.26%
5,800
+5,200
+867% +$493K
RMD icon
127
ResMed
RMD
$30.3B
$606K 0.26%
+10,486
New +$594K
OI icon
128
O-I Glass
OI
$1.39B
$600K 0.26%
37,600
+19,500
+108% +$279K
AXTA icon
129
Axalta
AXTA
$7.58B
$596K 0.25%
20,400
+11,400
+127% +$290K
UAL icon
130
United Airlines
UAL
$40.2B
$594K 0.25%
+9,925
New +$527K
SKX
131
DELISTED
Skechers
SKX
$585K 0.25%
19,200
+18,200
+1,820% +$548K
BRCD
132
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$582K 0.25%
55,000
+12,700
+30% +$116K
JAZZ icon
133
Jazz Pharmaceuticals
JAZZ
$16.1B
$574K 0.24%
+4,400
New +$548K
ATHM icon
134
Autohome
ATHM
$2.65B
$569K 0.24%
+20,348
New +$535K
CAA
135
DELISTED
CalAtlantic Group, Inc.
CAA
$569K 0.24%
+17,040
New +$533K
MSI icon
136
Motorola Solutions
MSI
$73.1B
$568K 0.24%
7,500
+4,700
+168% +$318K
HUM icon
137
Humana
HUM
$46.7B
$567K 0.24%
3,100
+2,000
+182% +$347K
SNV
138
DELISTED
Synovus
SNV
$567K 0.24%
19,600
+12,500
+176% +$358K
GM icon
139
General Motors
GM
$81.7B
$564K 0.24%
+17,936
New +$540K
SABR icon
140
Sabre
SABR
$743M
$561K 0.24%
19,400
+16,500
+569% +$440K
NTES icon
141
NetEase
NTES
$81.5B
$543K 0.23%
+18,925
New +$567K
AIZ icon
142
Assurant
AIZ
$14B
$540K 0.23%
+7,000
New +$531K
MRO
143
DELISTED
Marathon Oil Corporation
MRO
$534K 0.23%
+47,952
New +$448K
CRI icon
144
Carter's
CRI
$1.45B
$531K 0.23%
+5,035
New +$483K
TFCF
145
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$524K 0.22%
+18,599
New +$500K
ENOV icon
146
Enovis
ENOV
$1.7B
$523K 0.22%
10,632
+2,149
+25% +$91.4K
PNY
147
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$521K 0.22%
8,700
+5,600
+181% +$331K
PSEC icon
148
Prospect Capital
PSEC
$1.12B
$519K 0.22%
+71,378
New +$474K
CTAS icon
149
Cintas
CTAS
$86B
$514K 0.22%
+22,900
New +$491K
MS icon
150
Morgan Stanley
MS
$333B
$505K 0.21%
20,201
-3,900
-16% -$99.5K
4 5
6
7 8

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.

  • Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
  • Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
  • Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
  • Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
  • Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
  • Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
  • Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.

Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.